SCHEMBL442918

SCHEMBL442918

[O]C1CC2CCN1CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8637745 0.69
SCHEMBL4279010 0.67 SLC18A3 (0.35)
SCHEMBL701626 0.63
SCHEMBL2387150 0.63
SCHEMBL1920414 0.62
SCHEMBL3198068 0.62
SCHEMBL731350 0.62
SCHEMBL9550980 0.62
SCHEMBL3351081 0.62
SCHEMBL3198076 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080114007-A1 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2008-05-15 US claimed
WO-2008055013-A2 5-OXO-5,8 - DIHYDRO - PYRIDO - PYRIMIDINES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2008-05-08 WO claimed
EP-0644197-B1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors VERTEX PHARMA (US) 1998-09-09 EP claimed
US-5677283-A α-heteroaryloxymethyl ketones as interleukin - 1 β converting enzyme inhibitors SANOFI (FR) 1997-10-14 US claimed
EP-0644198-A1 Alpha-heteroaryloxymethyl ketones as interleukin-1beta converting enzyme inhibitors STERLING WINTHROP INC. (US) 1995-03-22 EP claimed
EP-0644197-A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors STERLING WINTHROP INC. (US) 1995-03-22 EP claimed
US-10787576-B2 Method for the preparation of a coating comprising oligomeric alkynes ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) EPFL-TTO (CH) 2020-09-29 US disclosed
US-10758492-B2 Two-dimensional polymeric structures and method for producing thereof Ecole polytechnique fédérale de Lausanne (EPFL) (CH) 2020-09-01 US disclosed
EP-3599239-A1 METAL ORGANIC FRAMEWORKS AND METHODS FOR USING THEREOF Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO (CH) 2020-01-29 EP disclosed
US-20190048202-A1 METHOD FOR THE PREPARATION OF A COATING COMPRISING OLIGOMERIC ALKYNES ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) EPFL-TTO (CH) 2019-02-14 US disclosed
US-20180171152-A1 METHOD FOR THE PREPARATION OF A COATING ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) EPFL-TTO (CH) 2018-06-21 US disclosed
EP-3303482-A1 METHOD FOR THE PREPARATION OF A COATING Ecole Polytechnique Fédérale de Lausanne (EPFL) EPFL-TTO (CH) 2018-04-11 EP disclosed
US-20170258737-A1 TWO-DIMENSIONAL POLYMERIC STRUCTURES AND METHOD FOR PRODUCING THEREOF Ecole polytechnique fédérale de Lausanne (EPFL) (CH) 2017-09-14 US disclosed
WO-1998054158-A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES RHÔNE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-12-03 WO disclosed
US-5843905-A Peptidic phosphinyloxymethyl ketones as interleukin-1β-converting enzyme inhibitors VERTEX PHARMACEUTICALS, INCORPORATED (US) 1998-12-01 US disclosed
EP-0644197-B1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors VERTEX PHARMA (US) 1998-09-09 EP disclosed
US-5677283-A α-heteroaryloxymethyl ketones as interleukin - 1 β converting enzyme inhibitors SANOFI (FR) 1997-10-14 US disclosed
US-5585357-A Heteroaryloxymethyl ketones as interleukin-1βconverting enzyme inhibitors SANOFI WINTHROP INC. (US) 1996-12-17 US disclosed
EP-0644198-A1 Alpha-heteroaryloxymethyl ketones as interleukin-1beta converting enzyme inhibitors STERLING WINTHROP INC. (US) 1995-03-22 EP disclosed
EP-0644197-A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors STERLING WINTHROP INC. (US) 1995-03-22 EP disclosed